The 'analysis of gene expression and biomarkers for point-of-care decision support in Sepsis' study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discrimination.

Front Immunol · 2023 · PMC10850284 · PMID 38332914

Europe PMC DOI

hedged sentence

0.0931

closest p · 1.9× alpha

0.0931

boldest claim

The sentences

approached significancep = 0.0931so close (0.05 < p ≤ 0.1)

S vs DNS ( Figure 2 ) small differences were seen for the SIRS and sepsis S and DNS groups, some of which approached significance/were significant (highlighted in bold); SIRS Day1 [lymphocytes (p = 0.0931), CRP (p = 0.1286)], Day2 (white blood cells (p = 0.0885), neutrophils (p = 0.1206) and basophils (p = 0.033) and Day5 (white blood cells (p = 0.0599), neutrophils (p = 0.0879) and lymphocytes (p = 0.1803).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.